{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:01:10Z","timestamp":1787925670447,"version":"build-2784847793"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T00:00:00Z","timestamp":1431475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0127054","type":"journal-article","created":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T18:08:27Z","timestamp":1431540507000},"page":"e0127054","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Mechanisms of Nifedipine-Downregulated CD40L\/sCD40L Signaling in Collagen Stimulated Human Platelets"],"prefix":"10.1371","volume":"10","author":[{"given":"Tso-Hsiao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Yu","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Lin","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tz-Chong","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,5,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"AJ Lusis","year":"2000","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1161\/01.HYP.0000123070.31763.55","article-title":"Modulation of the inflammatory response in cardiovascular disease","volume":"43","author":"DN Granger","year":"2004","journal-title":"Hypertension"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2174\/138161206776389877","article-title":"Pleiotropic effects of nifedipine on atherosclerosis","volume":"12","author":"S Yamagishi","year":"2006","journal-title":"Curr Pharm Des"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jacc.2009.03.076","article-title":"The CD40\/CD40 ligand system: linking inflammation with atherothrombosis","volume":"54","author":"C Antoniades","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.molmed.2008.09.006","article-title":"CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease","volume":"14","author":"M Rizvi","year":"2008","journal-title":"Trends Mol Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1161\/01.CIR.0000088521.04017.13","article-title":"Soluble CD40L: risk prediction after acute coronary syndromes","volume":"108","author":"N Varo","year":"2003","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/28204","article-title":"Reduction of atherosclerosis in mice by inhibition of CD40 signalling","volume":"394","author":"F Mach","year":"1998","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nm0302-247","article-title":"CD40L stabilizes arterial thrombi by a beta3 integrin\u2014dependent mechanism","volume":"8","author":"P Andre","year":"2002","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/01.RES.0000070111.98158.6C","article-title":"CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation","volume":"92","author":"DP Inwald","year":"2003","journal-title":"Circ Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/09537100903096684","article-title":"Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets","volume":"20","author":"S Reinboldt","year":"2009","journal-title":"Platelets"},{"key":"ref11","first-page":"581","article-title":"Platelet expression of CD40\/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation","volume":"232","author":"M Hammwohner","year":"2007","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref12","first-page":"w13071","article-title":"Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels","volume":"140","author":"A Yessoufou","year":"2010","journal-title":"Swiss Med Wkly"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"328172","DOI":"10.1155\/2008\/328172","article-title":"The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects","volume":"2008","author":"SL Spinelli","year":"2008","journal-title":"PPAR Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bcp.2012.06.022","article-title":"The antiplatelet activity of magnolol is mediated by PPAR-beta\/gamma","volume":"84","author":"CY Shih","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1096\/fj.05-4395fje","article-title":"Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARbeta","volume":"20","author":"FY Ali","year":"2006","journal-title":"FASEB J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/01.CIR.0000069272.06194.91","article-title":"Effect of rosiglitazone treatment on soluble CD40L in patients with type 2 diabetes and coronary artery disease","volume":"107","author":"N Marx","year":"2003","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood-2004-03-0926","article-title":"Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes","volume":"104","author":"F Akbiyik","year":"2004","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/sj.jhh.1002100","article-title":"Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus","volume":"21","author":"S Nomura","year":"2007","journal-title":"J Hum Hypertens"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/HJH.0000000000000007","article-title":"Mechanisms of antiplatelet activity of nifedipine: role of peroxisome proliferator-activated receptor-\u03b2-\u03b3-dependent processes","volume":"32","author":"CY Shih","year":"2014","journal-title":"J Hypertens"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"8596","DOI":"10.1021\/jf101518p","article-title":"Antiplatelet activity of alpha-lipoic acid","volume":"58","author":"YS Lai","year":"2010","journal-title":"J Agric Food Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nm810","article-title":"Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E","volume":"9","author":"Y Huo","year":"2003","journal-title":"Nat Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.2174\/092986707781389664","article-title":"Contribution of platelet-derived CD40 ligand to inflammation, thrombosis and neoangiogenesis","volume":"14","author":"P Ferroni","year":"2007","journal-title":"Curr Med Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0006-2952(00)00452-4","article-title":"Inhibition of agonist-induced p42 and p38 mitogen-activated protein kinase phosphorylation and CD40 ligand\/P-selectin expression by cyclic nucleotide-regulated pathways in human platelets","volume":"60","author":"UR Schwarz","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.bbamcr.2007.03.010","article-title":"p38 MAP-kinases pathway regulation, function and role in human diseases","volume":"1773","author":"A Cuenda","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1432-1033.1997.t01-1-00751.x","article-title":"Phosphorylation and activation of cytosolic phospholipase A2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets","volume":"245","author":"AG Borsch-Haubold","year":"1997","journal-title":"Eur J Biochem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1160\/TH04-03-0187","article-title":"Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation","volume":"92","author":"A Kuliopulos","year":"2004","journal-title":"Thromb Haemost"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.abb.2008.04.023","article-title":"HSP27 phosphorylation is correlated with ADP-induced platelet granule secretion","volume":"475","author":"H Kato","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.thromres.2009.12.003","article-title":"Mechanism of collagen-induced release of 5-HT, PDGF-AB and sCD40L from human platelets: role of HSP27 phosphorylation via p44\/p42 MAPK","volume":"126","author":"H Kato","year":"2010","journal-title":"Thromb Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/icb.2009.100","article-title":"PPAR-gamma agonist inhibits Ang II-induced activation of dendritic cells via the MAPK and NF-kappaB pathways","volume":"88","author":"Z Wei-guo","year":"2010","journal-title":"Immunol Cell Biol"},{"issue":"Suppl 1","key":"ref30","first-page":"S3","article-title":"Platelet physiology and antiplatelet agents","volume":"48","author":"T Thijs","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.atherosclerosis.2009.10.024","article-title":"Thromboxane A2 promotes soluble CD40 ligand release from human platelets","volume":"209","author":"Y Enomoto","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/0953770021000007203","article-title":"Differential actions of naftopidil, doxazosin and nifedipine on platelet thromboxane generation and platelet-derived growth factor efflux in vitro","volume":"13","author":"NA Alarayyed","year":"2002","journal-title":"Platelets"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/bph.12523","article-title":"Antiplatelet activity of nifedipine is mediated by inhibition of NF-\u03baB activation caused by enhancement of PPAR-\u03b2\/-\u03b3 activity","volume":"171","author":"CY Shih","year":"2014","journal-title":"Br J Pharmacol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry","volume":"92","author":"R Visse","year":"2003","journal-title":"Circ Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cardiores.2004.05.008","article-title":"Cyclic strain-mediated regulation of endothelial matrix metalloproteinase-2 expression and activity","volume":"63","author":"Sweeney N Von Offenberg","year":"2004","journal-title":"Cardiovasc Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/0886022X.2011.623498","article-title":"Pioglitazone reduces peritoneal fibrosis via inhibition of TGF-beta, MMP-2, and MMP-9 in a model of encapsulating peritoneal sclerosis","volume":"34","author":"F Saglam","year":"2012","journal-title":"Ren Fail"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"20919","DOI":"10.1074\/jbc.M109801200","article-title":"Activation of matrix metalloproteinase-2 by overexpression of manganese superoxide dismutase in human breast cancer MCF-7 cells involves reactive oxygen species","volume":"277","author":"HJ Zhang","year":"2002","journal-title":"J Biol Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0021-9258(18)52334-6","article-title":"Mutational analysis of the transin (rat stromelysin) autoinhibitor region demonstrates a role for residues surrounding the "cysteine switch","volume":"266","author":"AJ Park","year":"1991","journal-title":"J Biol Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1161\/01.ATV.0000184765.59207.f3","article-title":"CD40 ligand influences platelet release of reactive oxygen intermediates","volume":"25","author":"S Chakrabarti","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0127054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T02:08:56Z","timestamp":1651975736000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0127054"}},"subtitle":[],"editor":[{"given":"Markus Michael","family":"Bachschmid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,13]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0127054","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,13]]}}}